author-photo

Noboru Yamamoto

AstraZeneca

541

Papers

8328

Citations

Citation Trend

Filter By

Papers (393) Sort By

Journal Conference Others

Strength of unstiffened connection between beams and concrete filled tubular column

2021
Show All
- Source
- Cite
- Save
Citations (0)
First-in-human Phase 1 Study of MORAb-202, An Antibody-drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-positive Advanced Solid Tumors

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors.

2021 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (1)
980P Phase Ib study of a liposomal formulation of eribulin (E7389-LF) + nivolumab (Nivo) in patients (pts) with advanced solid tumors

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of incidental implantation of tumor cells after diagnostic needle biopsy in breast cancer patients

2021 The Breast
Show All
- Source
- Cite
- Save
Citations (0)
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study.

2021 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)